Global Single Nucleotide Polymorphism (SNP) Genotyping Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch＇s in-depth investigation and research, the global Single Nucleotide Polymorphism (SNP) Genotyping market size will reach 32,492 Million USD in 2025 and is projected to reach 116,561 Million USD by 2032, with a CAGR of 20.02% (2025-2032). Notably, the China Single Nucleotide Polymorphism (SNP) Genotyping market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Single nucleotide polymorphism (SNP) genotyping is a molecular technique used to detect and analyze variations in a single nucleotide within a DNA sequence among individuals or populations. SNPs are the most common type of genetic variation, where a single nucleotide base (A, T, C, or G) at a specific position in the genome differs between individuals. SNP genotyping involves identifying and determining the alleles present at specific SNP loci in DNA samples collected from individuals. This can be achieved using various methods, including polymerase chain reaction (PCR)-based assays, sequencing technologies, and microarray analysis. SNP genotyping is widely used in genetics research, personalized medicine, pharmacogenomics, and forensic science to study the genetic basis of diseases, identify genetic risk factors, assess drug responses, and determine individual ancestry or relatedness. It plays a crucial role in understanding the genetic diversity and variability within populations and has significant implications for improving healthcare outcomes and disease prevention strategies.
The major global suppliers of Single Nucleotide Polymorphism (SNP) Genotyping include Illumina, Affymetrix, Applied Biosystems, Agilent Technologies, Beckman Coulter, Roche, Qiagen, Luminex Corporation, Enzo Life Sciences, Bio-rad, GE Healthcare, Sequenom, Ocimum Biosolutions, GenScript, Douglas Scientific, BGI, Beijing Sunbiotech, HuaGene Biotech, Generay Biotech, Benegene, Shanghai Biochip, GENESKY, HD Biosciences, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Single Nucleotide Polymorphism (SNP) Genotyping. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Single Nucleotide Polymorphism (SNP) Genotyping market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Single Nucleotide Polymorphism (SNP) Genotyping market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Single Nucleotide Polymorphism (SNP) Genotyping industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Single Nucleotide Polymorphism (SNP) Genotyping Include:
Illumina
Affymetrix
Applied Biosystems
Agilent Technologies
Beckman Coulter
Roche
Qiagen
Luminex Corporation
Enzo Life Sciences
Bio-rad
GE Healthcare
Sequenom
Ocimum Biosolutions
GenScript
Douglas Scientific
BGI
Beijing Sunbiotech
HuaGene Biotech
Generay Biotech
Benegene
Shanghai Biochip
GENESKY
HD Biosciences
Single Nucleotide Polymorphism (SNP) Genotyping Product Segment Include:
Transversion
Transition
Single Nucleotide Polymorphism (SNP) Genotyping Product Application Include:
Diagnostics
Animal
Plant
Research
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Single Nucleotide Polymorphism (SNP) Genotyping Industry PESTEL Analysis
Chapter 3: Global Single Nucleotide Polymorphism (SNP) Genotyping Industry Porter's Five Forces Analysis
Chapter 4: Global Single Nucleotide Polymorphism (SNP) Genotyping Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Single Nucleotide Polymorphism (SNP) Genotyping Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Single Nucleotide Polymorphism (SNP) Genotyping Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch＇s in-depth investigation and research, the global Single Nucleotide Polymorphism (SNP) Genotyping market size will reach 32,492 Million USD in 2025 and is projected to reach 116,561 Million USD by 2032, with a CAGR of 20.02% (2025-2032). Notably, the China Single Nucleotide Polymorphism (SNP) Genotyping market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Single nucleotide polymorphism (SNP) genotyping is a molecular technique used to detect and analyze variations in a single nucleotide within a DNA sequence among individuals or populations. SNPs are the most common type of genetic variation, where a single nucleotide base (A, T, C, or G) at a specific position in the genome differs between individuals. SNP genotyping involves identifying and determining the alleles present at specific SNP loci in DNA samples collected from individuals. This can be achieved using various methods, including polymerase chain reaction (PCR)-based assays, sequencing technologies, and microarray analysis. SNP genotyping is widely used in genetics research, personalized medicine, pharmacogenomics, and forensic science to study the genetic basis of diseases, identify genetic risk factors, assess drug responses, and determine individual ancestry or relatedness. It plays a crucial role in understanding the genetic diversity and variability within populations and has significant implications for improving healthcare outcomes and disease prevention strategies.
The major global suppliers of Single Nucleotide Polymorphism (SNP) Genotyping include Illumina, Affymetrix, Applied Biosystems, Agilent Technologies, Beckman Coulter, Roche, Qiagen, Luminex Corporation, Enzo Life Sciences, Bio-rad, GE Healthcare, Sequenom, Ocimum Biosolutions, GenScript, Douglas Scientific, BGI, Beijing Sunbiotech, HuaGene Biotech, Generay Biotech, Benegene, Shanghai Biochip, GENESKY, HD Biosciences, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Single Nucleotide Polymorphism (SNP) Genotyping. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Single Nucleotide Polymorphism (SNP) Genotyping market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Single Nucleotide Polymorphism (SNP) Genotyping market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Single Nucleotide Polymorphism (SNP) Genotyping industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Single Nucleotide Polymorphism (SNP) Genotyping Include:
Illumina
Affymetrix
Applied Biosystems
Agilent Technologies
Beckman Coulter
Roche
Qiagen
Luminex Corporation
Enzo Life Sciences
Bio-rad
GE Healthcare
Sequenom
Ocimum Biosolutions
GenScript
Douglas Scientific
BGI
Beijing Sunbiotech
HuaGene Biotech
Generay Biotech
Benegene
Shanghai Biochip
GENESKY
HD Biosciences
Single Nucleotide Polymorphism (SNP) Genotyping Product Segment Include:
Transversion
Transition
Single Nucleotide Polymorphism (SNP) Genotyping Product Application Include:
Diagnostics
Animal
Plant
Research
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Single Nucleotide Polymorphism (SNP) Genotyping Industry PESTEL Analysis
Chapter 3: Global Single Nucleotide Polymorphism (SNP) Genotyping Industry Porter's Five Forces Analysis
Chapter 4: Global Single Nucleotide Polymorphism (SNP) Genotyping Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Single Nucleotide Polymorphism (SNP) Genotyping Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Single Nucleotide Polymorphism (SNP) Genotyping Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 Single Nucleotide Polymorphism (SNP) Genotyping Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Single Nucleotide Polymorphism (SNP) Genotyping Product by Type
- 1.2.1 Transversion
- 1.2.2 Transition
- 1.3 Single Nucleotide Polymorphism (SNP) Genotyping Product by Application
- 1.3.1 Diagnostics
- 1.3.2 Animal
- 1.3.3 Plant
- 1.3.4 Research
- 1.3.5 Others
- 1.4 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Analysis (2020-2032)
- 1.5 Single Nucleotide Polymorphism (SNP) Genotyping Market Development Status and Trends
- 1.5.1 Single Nucleotide Polymorphism (SNP) Genotyping Industry Development Status Analysis
- 1.5.2 Single Nucleotide Polymorphism (SNP) Genotyping Industry Development Trends Analysis
- 2 Single Nucleotide Polymorphism (SNP) Genotyping Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Single Nucleotide Polymorphism (SNP) Genotyping Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Analysis by Country
- 4.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue Analysis by Country (2020-2025)
- 4.1.2 Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue Forecast Analysis by Country (2026-2032)
- 4.2 United States Single Nucleotide Polymorphism (SNP) Genotyping Market Revenue and Growth Rate (2020-2032)
- 4.3 Germany Single Nucleotide Polymorphism (SNP) Genotyping Market Revenue and Growth Rate (2020-2032)
- 4.4 Japan Single Nucleotide Polymorphism (SNP) Genotyping Market Revenue and Growth Rate (2020-2032)
- 4.5 China Single Nucleotide Polymorphism (SNP) Genotyping Market Revenue and Growth Rate (2020-2032)
- 4.6 France Single Nucleotide Polymorphism (SNP) Genotyping Market Revenue and Growth Rate (2020-2032)
- 4.7 U.K. Single Nucleotide Polymorphism (SNP) Genotyping Market Revenue and Growth Rate (2020-2032)
- 4.8 South Korea Single Nucleotide Polymorphism (SNP) Genotyping Market Revenue and Growth Rate (2020-2032)
- 4.9 Canada Single Nucleotide Polymorphism (SNP) Genotyping Market Revenue and Growth Rate (2020-2032)
- 4.10 Italy Single Nucleotide Polymorphism (SNP) Genotyping Market Revenue and Growth Rate (2020-2032)
- 4.11 Russia Single Nucleotide Polymorphism (SNP) Genotyping Market Revenue and Growth Rate (2020-2032)
- 4.12 Mexico Single Nucleotide Polymorphism (SNP) Genotyping Market Revenue and Growth Rate (2020-2032)
- 4.13 Brazil Single Nucleotide Polymorphism (SNP) Genotyping Market Revenue and Growth Rate (2020-2032)
- 4.14 India Single Nucleotide Polymorphism (SNP) Genotyping Market Revenue and Growth Rate (2020-2032)
- 4.15 Vietnam Single Nucleotide Polymorphism (SNP) Genotyping Market Revenue and Growth Rate (2020-2032)
- 4.16 Thailand Single Nucleotide Polymorphism (SNP) Genotyping Market Revenue and Growth Rate (2020-2032)
- 4.17 South Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Revenue and Growth Rate (2020-2032)
- 5 Competition by Suppliers
- 5.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Revenue by Key Suppliers (2021-2025)
- 5.2 Global Single Nucleotide Polymorphism (SNP) Genotyping Competitive Landscape Analysis and Market Dynamic
- 5.2.1 Single Nucleotide Polymorphism (SNP) Genotyping Competitive Landscape Analysis
- 5.2.2 Global Key Suppliers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 Single Nucleotide Polymorphism (SNP) Genotyping Market Analysis by Type
- 6.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Analysis by Type: 2024 VS 2025 VS 2032
- 6.2 Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Forecast Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 Illumina
- 7.1.1 Illumina Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 Illumina Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio
- 7.1.3 Illumina Single Nucleotide Polymorphism (SNP) Genotyping Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.2 Affymetrix
- 7.2.1 Affymetrix Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 Affymetrix Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio
- 7.2.3 Affymetrix Single Nucleotide Polymorphism (SNP) Genotyping Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.3 Applied Biosystems
- 7.3.1 Applied Biosystems Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 Applied Biosystems Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio
- 7.3.3 Applied Biosystems Single Nucleotide Polymorphism (SNP) Genotyping Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.4 Agilent Technologies
- 7.4.1 Agilent Technologies Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 Agilent Technologies Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio
- 7.4.3 Agilent Technologies Single Nucleotide Polymorphism (SNP) Genotyping Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.5 Beckman Coulter
- 7.5.1 Beckman Coulter Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 Beckman Coulter Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio
- 7.5.3 Beckman Coulter Single Nucleotide Polymorphism (SNP) Genotyping Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.6 Roche
- 7.6.1 Roche Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 Roche Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio
- 7.6.3 Roche Single Nucleotide Polymorphism (SNP) Genotyping Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.7 Qiagen
- 7.7.1 Qiagen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.7.2 Qiagen Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio
- 7.7.3 Qiagen Single Nucleotide Polymorphism (SNP) Genotyping Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.8 Luminex Corporation
- 7.8.1 Luminex Corporation Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.8.2 Luminex Corporation Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio
- 7.8.3 Luminex Corporation Single Nucleotide Polymorphism (SNP) Genotyping Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.9 Enzo Life Sciences
- 7.9.1 Enzo Life Sciences Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.9.2 Enzo Life Sciences Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio
- 7.9.3 Enzo Life Sciences Single Nucleotide Polymorphism (SNP) Genotyping Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.10 Bio-rad
- 7.10.1 Bio-rad Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.10.2 Bio-rad Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
